Purple biotech to present at the b. riley oncology investor conference

Rehovot, israel, jan. 18, 2021 (globe newswire) -- purple biotech ltd. (“purple biotech”) (nasdaq/tase: ppbt), a clinical-stage company advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, today announced that the purple biotech management team will present a corporate overview at the b. riley oncology investor conference, being held virtually january 20-21, 2021.
PPBT Ratings Summary
PPBT Quant Ranking